Celltrion
068270.KS
#804
Rank
โ‚ฌ23.41 B
Marketcap
113,06ย โ‚ฌ
Share price
1.39%
Change (1 day)
1.83%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: โ‚ฌ23.41 Billion

As of November 2024 Celltrion has a market cap of โ‚ฌ23.41 Billion. This makes Celltrion the world's 804th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2024

End of year Market Cap

Year Marketcap Change
2024โ‚ฌ23.41 B-22.68%
2023โ‚ฌ30.28 B79.19%
2022โ‚ฌ16.90 B-17.45%
2021โ‚ฌ20.47 B-44.15%
2020โ‚ฌ36.65 B106.25%
2019โ‚ฌ17.77 B-18.13%
2018โ‚ฌ21.70 B1.2%
2017โ‚ฌ21.45 B107.57%
2016โ‚ฌ10.33 B39.82%
2015โ‚ฌ7.39 B148.23%
2014โ‚ฌ2.97 B15.29%
2013โ‚ฌ2.58 B-21.37%
2012โ‚ฌ3.28 B16.83%
2011โ‚ฌ2.81 B8.49%
2010โ‚ฌ2.59 B181.57%
2009โ‚ฌ0.92 B59.55%
2008โ‚ฌ0.57 B4409.11%
2007โ‚ฌ12.79 M